News

Nearly 90% of its revenue is from its subsea division, which includes underwater production machinery and undersea robotics.

The blue chip energy leader still has plenty of irons in the fire.

Select Water Solutions isn't the first energy stock on many investors' list. Maybe it ought to be.

Chevron's rising production, strong cash returns and expanding high-margin oil assets are driving renewed investor optimism in 2026.

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner at Cerity Partners, said Exxon Mobil Corporation (NYSE:XOM) continues to bring money while energy prices are high. Lending support to his choice, Exxon Mobil, on May 1, reported better-than-expected results for the first quarter. Adjusted earnings were $4.9 billion, or $1.16 per share, while earnings excluding identified items and estimated timing effects were $8.8 billion, or $2.09 per share. Jason Snipe, founder and chief investm

We just covered Grok’s Latest Stock Portfolio in 2026: Elon Musk’s AI Chatbot’s Top 10 Stock Picks. Sable Offshore (NYSE:SOC) ranks #10 (see Grok’s Latest Stock Portfolio in 2026: AI Assistant’s Top 5 Stock Picks). Number of Hedge Funds: 35 Oil and gas company Sable Offshore (NYSE:SOC) is focused on restarting production from the Santa […]

Investors may be wondering whether Exxon Mobil at around US$149.68 is still offering value or if most of the upside has already been priced in. The stock has pulled back slightly, with returns declining 2.6% over the past week and 1.9% over the past month. It is still up 22.0% year to date and 41.8% over the past year. Recent headlines around Exxon Mobil have largely focused on its position in the global energy sector and investor interest in large integrated oil companies. This continues to...

With an annual dividend yield of 2.75%, Exxon Mobil Corporation (NYSE:XOM) is included among the 12 Best Blue Chip Dividend Stocks to Buy Now. Exxon Mobil Corporation (NYSE:XOM) is one of the largest integrated fuels, lubricants, and chemical companies in the world. On May 4, UBS increased its price target on Exxon Mobil Corporation (NYSE:XOM) from $171 […]

The Horizon Kinetics Inflation Beneficiaries ETF has surged this year as oil and commodity prices climbed. But a reversal in energy markets could hit the fund hard.

Occidental, Chevron, and ExxonMobil are no-brainer buys amid the Iran war.

An ETF has done something unusual for a leveraged commodity fund. It has actually rewarded holders. ProShares Ultra Bloomberg Crude Oil (NYSEARCA:UCO) is up 130% year to date, the kind of move that pays for past pain in a fund notorious for grinding holders down. With President Trump’s April 7 announcement of a two-week US-Iran ... Up 130% YTD, This ETF Can Double Again as Iran War Has No End in Sight

The Dow Jones Industrial Average would be even higher if it had more exposure to energy stocks.

Wall Street closed slightly higher on Monday, driven by energy and industrial stocks.

The oil stock has fallen from its recent highs. Here's why it could surge again.

Exxon, The AES and American Express, have been highlighted in this Market Edge article.

These energy stocks offer strong cash flow, durable balance sheets, and downside resilience in a volatile market.

ExxonMobil’s first quarter results were shaped by its ability to respond to significant disruptions in the global energy market while maintaining operational reliability. Management highlighted that increased oil production in the Permian and Guyana helped offset external impacts, such as conflicts in the Middle East and weather events in key production regions. CEO Darren Woods emphasized that the company’s diverse asset base and scale allowed it to “respond quickly and manage effectively throu

Major US and European oil companies, including Exxon Mobil, are moving to re enter Venezuela following a regime change and a shift in US policy. A new hydrocarbon law in Venezuela is offering more favorable terms for international investment in the country’s oil sector. Exxon Mobil is assessing potential projects after previously exiting the country when its assets were nationalized. For investors watching Exxon Mobil (NYSE:XOM), the renewed access to Venezuela comes as the stock trades...

SHEL's Q1 beat, buybacks and dividend hike highlight strong cash visibility and trading strength amid volatility.

BP (NYSE:BP) just received a rare same-day double upgrade from Wall Street. Argus moved BP stock to Buy from Hold, and RBC Capital lifted the stock to Outperform from Sector Perform with a 700 GBp price target. The simultaneous bullish shift signals coordinated conviction that BP’s recovery story is finally taking shape under new CEO ... BP Just Got a Wall Street Double Upgrade: Argus, RBC Both Turn Bullish on Recovery Story

Tracey Ryniec and John Blank discuss the US economy and what stocks to buy right now.

Dallas Fed models show a 3-quarter Iran War oil shock could lift core inflation and push oil to $167, reshaping sector outlooks.

A week after US troops smuggled then-president Nicolas Maduro out of Venezuela in early January, the boss of ExxonMobil told Donald Trump that the oil-rich, dirt-poor country was “uninvestable”.

A week after US troops smuggled then-president Nicolas Maduro out of Venezuela in early January, the boss of ExxonMobil told Donald Trump that the oil-rich, dirt-poor country was “uninvestable”.

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

European oil and gas companies that posted huge profits in the first quarter on soaring prices caused by the war in the Middle East face new calls from London to Paris to tax their outsized gains.View on euronews

Shell's CEO is warning that the world has a 1 billion-barrel hole to dig out of, and it could get worse before it gets better.

The stock market keeps rolling along as if nothing can stop it. The S&P 500 recently hit another all-time high, unemployment remains low at 4.3%, and payroll growth has continued to beat expectations, according to the latest Bureau of Labor Statistics report. President Donald Trump has pointed to both as proof the economy remains on ... What Saudi Aramco’s CEO Just Said Has Huge Implications for the Trump Bull Market

This clinical-stage biotech develops oral therapeutics for chronic diseases, targeting large global markets with unmet medical needs.

Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition technology.